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The immensely diverse and rich human gut microbiome 
has a huge potential to impact health and disease (1). Gut 
microbiome dysbiosis has been associated with gastro-
intestinal inflammatory conditions and extra-intestinal 
disorders; such as stroke, depression, neurodegenerative, 
cardiovascular and metabolic disorders (2-6). In the 
September 2018 issue of nature communications, Chen 
and colleagues report the findings from a study that found 
commensal microflora-induced T cell responses mediate 
progressive neurodegeneration in glaucoma, in mouse 
glaucoma models (7). 
This investigation sheds some light on intersecting 
mechanistic pathways in glaucomatous neurodegeneration. 
Progressive degeneration of retinal ganglion cells (RGCs) 
resulting in optic nerve head cupping and visual loss are 
characteristic features of glaucoma. The pathophysiological 
causes of this degeneration are not clearly defined but most 
certainly involves multifactorial and polygenic mechanisms. 
Large genome-wide association studies suggest a role of 
angiopoietin-receptor tyrosine kinase signalling, lipid 
metabolism, mitochondrial function, and developmental 
processes as underlying risks for elevated intraocular 
pressure (IOP) and primary open angle glaucoma 
(POAG) (8). Although age and raised IOP remain the most 
prominent risk factors for glaucoma, disease phenotypes 
of normal tension glaucoma suggest mechanisms beyond 
pressure-mediated neurodegeneration. 
Elevated IOP can cause retinal ganglion degeneration 
via various pathways such as mechanical stress, metabolic 
stress, and immune response. Firstly, mechanical stress on 
the lamina cribosa and surrounding tissues damages retinal 
ganglion axons and disrupts axonal transport of trophic 
factors (9). Secondly, mitochondrial dysfunction in RGCs 
and astrocytes due to ageing may not meet metabolic 
demands in IOP-induced metabolic stress (10). Thirdly, 
elevated IOP can also trigger an immune response. It is 
this autoimmune response to commensal microflora that 
is thought to mediate neurodegeneration through the 
production of activated retinal T cells. Chen et al. showed 
elevated IOP induces two phases of retinal damage; the 
acute phase likely mediated by mechanical stress; the 
prolonged retinal degeneration, which continues after IOP 
has returned to normal, mediated by T cells (7). 
There is an established body of evidence for linking 
gut microflora to some brain diseases. Gut dysbiosis and 
reduced diversity of gut microflora may be a factor in the 
development of neurodegeneration via neuroinflammation 
mechanisms in Alzheimer’s disease, Parkinson’s disease, 
multiple sclerosis and amyotrophic lateral sclerosis 
(ALS) (6). Although these diseases have distinct clinical 
manifestations, they are all associated with normal ageing. 
With ageing, the diversity of gut microflora reduces 
impacting a complex interlocking of hormonal and 
biochemical pathways linking gut health to the brain (11). 
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There is a lack of evidence showing the influence of 
commensal microflora on ophthalmic diseases. Although 
it is known commensal ocular microbiome and infectious 
factor have a role in the development of ocular adnexal 
malignancies (12,13); there is limited evidence linking 
commensal gut microflora and glaucoma progression. 
In summary Chen et al. showed (I) elevation of IOP 
induces retinal T-cell infiltration, (II) T cells mediate 
prolonged retinal neurodegeneration, (III) IOP elevation 
activates T-cell responses to heat shock proteins (HSP), 
(IV) HSP-specif ic T cells  augment glaucomatous 
neurodegeneration, (V) absence of glaucomatous neural 
damage in GF mice and (VI) HSP-specific T cells increased 
in patients with glaucoma.
Chen et al. showed short (3 weeks) elevation of IOP 
using microbead injection B6 mouse model and progressive 
elevation of IOP using genetic (DBA/2J) mice model, 
induces infiltration of IFN-γ-secreting T cells resulting 
in the reduction of RGC density and axonal loss (7). For 
retinal T cell infiltration to occur local inflammation is 
required. More specifically, T cells CD4+ T cells mediate 
the progressive phase of neurodegeneration after the 
initial induction of elevated IOP with microbeads in 
immunocompromised mice models. T cell and B cell 
deficient mice (Rag1−/−) did not exhibit progressive loss of 
RGCs or axons from 2 to 8 weeks post microbead injection 
when IOP returned to normal levels. CD4+ T cells were 
transferred from B6 mice into Rag1−/− mice via the tail vein 
to assess if CD4+ T cells had a causal role in the progression 
of the glaucomatous neurodegeneration. Rag1−/− mice which 
received T cells from glaucomatous B6 mice showed a T 
cell infiltration and a significant further decrease in RGC 
density and axon numbers (7). 
Elevated IOP induced IFN-γ-secreting T cells were 
found to be specific for heat shock proteins (HSP). T cells 
from GFP transgenic mice immunised with HSP-27 were 
transferred to immunocompromised glaucomatous Rag1−/− 
mice to confirm retinal infiltration occurs. When compared 
to controls, recipient Rag1−/− mice had an approximately 
15-fold increase in GFP+ retinas −/−T cells, following T 
cell transfer from HSP-27 immunised mice. Furthermore, 
HSP-27 specific T cells induced progressive glaucomatous 
damage. Recipient B6 mice that received CD4+ T cells from 
HSP-27 immunised mice exhibited a significantly higher 
loss of RGCs and axons compared to controls. Induction of 
HSP specific T cells and glaucomatous neurodegeneration 
by elevated IOP require  exposure to commensal 
microflora. Elevated IOP induced retinal T cell infiltration, 
HSP-27 and HSP-60 specific T cell responses were 
detected in normally colonised mice but not detected in 
germ-free mice (7). 
HSPs have a cellular protective effect and are upregulated 
in stressful conditions and can promote recovery from 
stress. However, HSPs are also highly antigenic, and 
immune responses to HSPs could contribute to glaucoma 
progression (14). Intracellular HSP-27 is highly inducible 
in the retinal glial cells and acts in an anti-apoptotic manner. 
HSP-27 antibodies result in RGC apoptosis by destabilising 
actin cytoskeleton (15,16). Chen et al. found the frequency 
of HSP-27 and HSP-60 specific T cells and antibodies 
were higher in both POAG and normal tension glaucoma 
(NTG) patients when compared to age-matched healthy 
individuals (7). The number of peripheral blood samples 
included in the study was limited so there remains 
uncertainty regarding the estimate effect size and direction.
Chen et al. study (7) should be commended for its 
methodological robustness in demonstrating intersecting 
pathways in glaucomatous neurodegeneration in a mouse 
model. Understanding these mechanisms will help identify 
upstream factors to exploit in the prevention or treatment 
of glaucoma. Elevated IOP is unlikely to be the only 
trigger for glaucomatous neurodegeneration. Metabolic 
stress due to age-related mitochondrial dysfunction and 
the subsequent accumulation of reactive oxygen species 
in neurons can stimulate cytokine release and microglial 
activation and neuroinflammation (17). RGCs have a high 
energy demand making them sensitive to oxidative damage. 
In the context of ageing, this can present as a chronic 
low-grade pro-inflammatory response. Other stress 
conditions could also lead to retinal T cell infiltration and 
immune-mediated neural damage (18). 
A likely explanation of the gut-eye axis is the proximity 
of immune cells along the gastrointestinal tract and 
dysfunction of the blood-retinal barrier when under 
stressed conditions. Antigen-presenting innate immune 
cells embedded in the subepithelial lamina propria tissue 
of the digestive tract are close to the gut microflora (19). 
Toll-like and NOD-like receptors on these cells recognise 
the pathogen-associated molecular patterns, which trigger 
signalling cascades leading to pro- or anti-inflammatory 
cytokine expression (20). The blood-retinal barrier can 
be compromised by stressed conditions such as elevated 
IOP but also by other factors. Elevated IOP causes local 
inflammation in the retina and optic nerve inducing T 
cell infiltration. T cells specific to bacterial HSP can be 
activated by host HSPs through molecular mimicry under 
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stress conditions such as elevated IOP, leading to immune-
mediated neural damage (7). There are many homologies 
between bacteria and human proteins making HSP unlikely 
to be the only cross-reacting antigen for retinal T cells. 
Elucidating culpable antigens in the gut-eye axis in humans 
with glaucoma is complex and cannot be underestimated.
Other research groups have identified links between 
glaucoma and microflora in the oral cavity and gut. Oral 
bacterial loads (16S rRNA) of patients with glaucoma 
were found to be higher than healthy controls in a study 
population that was predominantly African American (21). 
This study did not use age-matched controls. Low dose 
subcutaneous bacterial lipopolysaccharide (LPS) was 
injected into two glaucoma mouse models (spontaneous 
and induced) to simulate the conditions expected in chronic 
subclinical bacterial infections. LPS administration resulted 
in axonal degeneration via microglial activation at the optic 
nerve and retina, upregulation of toll-like receptor 4 (TLR4) 
signalling and complement cascade (21). 
Studies have shown a link between Helicobacter pylori and 
glaucoma measuring increased titres of antibodies against 
Helicobacter pylori in POAG patients (22-25). When taken 
together these studies suggest a common factor such as 
gut dysbiosis that causes susceptibilities to both POAG 
and H.pylori infection. Gut microflora plays a role in the 
activation of microglial activation in the central nervous 
system (CNS). Host microflora by-products were found 
to regulate microglial homeostasis in terms of maturation, 
differentiation, and function (26). The exact mechanism by 
which human host microflora may activate the innate or 
adaptive immunity of retina or optic nerve is not yet well 
understood.
A variety of host, genetic, environmental and behavioural 
factors, as well as various pathological states can alter host 
gut microflora (27). Thus, making microbiome research 
in humans challenging and difficult to control. Advances 
in next-generation sequencing and bioinformatics will 
undoubtedly help generate a greater understanding of the 
composition and function of gut microflora and its influence 
on the pathogenesis of glaucoma. More research is needed 
to determine transcriptional activity, protein expression and 
metabolic by-products profiles of host microflora to identify 
potential biomarkers of gut dysbiosis that lead to glaucoma 
progression. More evidence using from gnotobiotic animal 
models and functional observational studies are required 
before an investment into large scale longitudinal clinical 
trials (28). Human longitudinal studies starting in the 
earlier disease phases would be preferential to understand 
the causative relation between microflora and glaucomatous 
neurodegeneration and to develop treatments aimed at 
halting the progression of optic nerve damage.
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